WESTFORD, Mass., April 30,
2024 /PRNewswire-PRWeb/ -- Crescent Innovations
Inc. announced today the sale of its Poly-gamma-glutamic Acid
(PgGA) technology related to osteoarthritis (OA), plus various
intellectual property and know-how assets. Chris Finn, President of the advisory firm
Alternotio announced today that Crescent Innovations has retained
Alternotio to sell the assets using a sealed bid sales process
concluding on June 28, 2024 at
12 PM EDT.
"Crescent Innovations has shown, both
in vitro and in vivo, that...PgGA...reduce[s] MMPs and other
inflammatory marker[s] far greater than HA." Al Prescott, President Crescent Innovations
Inc.
PgGA was developed as the next generation of viscosupplements
for treat degenerative joint disease. Over 20 million people in
the United States suffer from
degenerative joint diseases. This results in over 2 million
arthroscopic surgeries and about 250,000 knee and hip replacements
each year and a healthcare burden of over $1
billion dollars every year.
PgGA, while polyanionic like the current state of the art OA
treatment, hyaluronic acid (HA), is unique in its charge density.
PgGA has triple the charge density of HA. Crescent Innovations has
shown, both in vitro and in vivo, that this allows PgGA to reduce
MMPs and other inflammatory marker far greater than HA.
PgGA has been tested in disease models and ISO standard
bio-compatibility tests.
The assets will be sold at a sealed bid sale on June 28, 2024, at noon. Parties interested in
purchasing any or all of the assets must sign a confidentiality
agreement, which can be obtained by contacting Chris Finn at info@alternotio.com or calling +1
(978) 882 - 2586. Negotiated offers are welcome, but any negotiated
sale must be concluded prior to opening bids on the date specified
above and must conform to the terms set forth for sealed bids.
About Crescent Innovations Inc.
Crescent Innovations Inc. is a firm focused on the development
of biological polymers to create non surgical regenerative
solutions for chronic conditions. The firm currently is focused on
innovating technology to solve TMJ disorders and singular maladies.
If interested in TMJ disorders, please contact Crescent Innovations
directly at www.crescentinnovations.com
About Alternotio.
Alternotio is an advisory firm, that specializes in the sale of
non-lead and distressed intellectual property. Alternotio
occasionally works with unique tangible assets that have a
substantial intellectual property component.
www.alternotio.com
Media Contact
Al Prescott, Crescent Innovations
Inc., 1 9787648604, alprescott@crescentinnovations.com,
www.crescentinnovations.com
View original content to download
multimedia:https://www.prweb.com/releases/crescent-innovations-offers-breakthrough-osteoarthritis-treatment-technology-for-sale-and-its-impact-on-orthopedics-302128299.html
SOURCE Crescent Innovations Inc.